Source: Annual Congress 2002 - Health effects of pollution
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Blomberg, M. Svensson, X. Dumont, R. Helleday, G. Nordberg, A. Bernard (Umeå, Sweden; Brussels, Belgium). Clara cell protein (CC16) as a biomarker for ozone exposure in humans. Eur Respir J 2002; 20: Suppl. 38, 3528

Member's Comments

No comment yet.

Related content which might interest you: Clara cell protein as a biomarker for ozone-induced lung injury in humans Source: Eur Respir J 2003 Dec 01;22(6):883-888 Year: 2003 Clara cell specific protein (CC16) after LPS inhalation in healthy subjects Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003 Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Diurnal variation in the serum levels of Clara cell protein (CC16) in humans Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003 Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Source: Eur Respir J 2002; 20: 1152-1161 Year: 2002 The effect of occupational exposure to glutaraldehyde on serum Clara cell protein Source: Eur Respir J 2002; 20: Suppl. 38, 603s Year: 2002 Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis Source: Eur Respir J 2001; 18: 507-514 Year: 2001 Clara cell secretory protein (CC16): possibility of detection in exhaled breath condensate Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Decrease of serum Clara cell protein-16 and increase of exhaled NO induced by short-term exposure to traffic pollution in healthy subjects Source: Annual Congress 2008 - The air we breathe indoors and outdoors Year: 2008 Swimmers have evidence of epithelial dysfunction measured as increased urinary concentration of Clara cell protein (CC16) after swim exercise Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Clara cells drive eosinophil accumulation in allergic asthma Source: Eur Respir J 2012; 39: 429-438 Year: 2012 Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites Source: International Congress 2014 – Environment and mechanisms Year: 2014 Similar sputum secretory leykocyte inhibitor and Clara cell protein 16 levels between current and ex-smokers with COPD Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Production of Clara cell protein by human bronchiolar epithelial cells is reduced by INF-gamma Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004 Biomarkers of early respiratory effects in smoking adolescents Source: Eur Respir J 2011; 38: 1287-1293 Year: 2011 Neutrophil predominance phenotype in bronchial asthma. Therapeutic implication and the role of Clara cell 16-kD protein Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 Clara cells protein 16 (CC-16) level correlates with hemoglobin level in COPD patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Sputum secretory leukocyte inhibitor and Clara cell protein 16 levels are not altered after 6 month and 1 year smoking cessation Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008